![ShareCast](https://static.lse.co.uk/images/news-logos/sharecast-news-logo.png)
Oxford Biomedica swings to loss as licensing revenue falls
(Sharecast News) - Gene and cell therapy company Oxford Biomedica reported an improvement in bioprocessing and commercial development revenues to ?47.3m in its preliminary results on Wednesday, from ?40.5m.
Read more